Emerging roles of the myocardin family of proteins in lipid and glucose metabolism

Journal of Physiology

Volumn 594, Issue 17, 2016, Pages 4741-4752

  Swärd, Karl ^a   Stenkula, Karin G ^a   Rippe, Catarina ^a   Alajbegovic, Azra ^a   Gomez, Maria F ^b   Albinsson, Sebastian ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCARDIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; MYOCARDIN RELATED TRANSCRIPTION FACTOR B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REGULATOR PROTEIN; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ADIPOCYTE; ADIPOGENESIS; CAVEOLA; CELL DIFFERENTIATION; DIABETES MELLITUS; FAT MASS; GENE CONTROL; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; UPREGULATION;

EID: 84986296986     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271913     Document Type: Review

References (85)

1. Abebe W, Harris KH & MacLeod KM (1990). Enhanced contractile responses of arteries from diabetic rats to α1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 16, 239–248.
2. Albinsson S & Hellstrand P (2007). Integration of signal pathways for stretch-dependent growth and differentiation in vascular smooth muscle. Am J Physiol Cell Physiol 293, C772–C782.
3. Albinsson S, Nordstrom I & Hellstrand P (2004). Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization. J Biol Chem 279, 34849–34855.
4. Aravind L & Koonin EV (2000). SAP – a putative DNA-binding motif involved in chromosomal organization. Trends Biochem Sci 25, 112–114.
5. Asparuhova MB, Ferralli J, Chiquet M & Chiquet-Ehrismann R (2011). The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress. FASEB J 25, 3477–3488.
6. Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, Lo HP, Abankwa D, Luetterforst R, Fernandez-Rojo M, Breen MR, Gygi SP, Vinten J, Walser PJ, North KN, Hancock JF, Pilch PF & Parton RG (2009). MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J Cell Biol 185, 1259–1273.
7. Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H & Gu C (2014). Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 509, 507–511.
8. Black BL & Olson EN (1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14, 167–196.
9. Blank RS, McQuinn TC, Yin KC, Thompson MM, Takeyasu K, Schwartz RJ & Owens GK (1992). Elements of the smooth muscle α-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation. J Biol Chem 267, 984–989.
10. 1-integrin. Nat Cell Biol 11, 557–568.
11. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME & El-Osta A (2009). Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229–1236.
12. Cheng JP, Mendoza-Topaz C, Howard G, Chadwick J, Shvets E, Cowburn AS, Dunmore BJ, Crosby A, Morrell NW & Nichols BJ (2015). Caveolae protect endothelial cells from membrane rupture during increased cardiac output. J Cell Biol 211, 53–61.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr & Roccella EJ (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560–2572.
14. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE & Lisanti MP (2003). Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285, C222–C235.
15. Collard L, Herledan G, Pincini A, Guerci A, Randrianarison-Huetz V & Sotiropoulos A (2014). Nuclear actin and myocardin-related transcription factors control disuse muscle atrophy through regulation of Srf activity. J Cell Sci 127, 5157–5163.
16. Creemers EE, Sutherland LB, Oh J, Barbosa AC & Olson EN (2006). Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol Cell 23, 83–96.
17. Cui Y, Hameed FM, Yang B, Lee K, Pan CQ, Park S & Sheetz M (2015). Cyclic stretching of soft substrates induces spreading and growth. Nat Commun 6, 6333.
18. De Marinis Y, Cai M, Bompada P, Atac D, Kotova O, Johansson ME, Garcia-Vaz E, Gomez MF, Laakso M & Groop L (2016). Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney. Kidney Int 89, 342–353.
19. Echarri A & Del Pozo MA (2015). Caveolae – mechanosensitive membrane invaginations linked to actin filaments. J Cell Sci 128, 2747–2758.
20. Esnault C, Stewart A, Gualdrini F, East P, Horswell S, Matthews N & Treisman R (2014). Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev 28, 943–958.
21. Fintha A, Gasparics A, Fang L, Erdei Z, Hamar P, Mozes MM, Kokeny G, Rosivall L & Sebe A (2013). Characterization and role of SCAI during renal fibrosis and epithelial-to-mesenchymal transition. Am J Pathol 182, 388–400.
22. 2+ distribution. Diabetes 48, 1323–1330.
23. Gomez-Ruiz A, Milagro FI, Campion J, Martinez JA & de Miguel C (2010). Caveolin expression and activation in retroperitoneal and subcutaneous adipocytes: influence of a high-fat diet. J Cell Physiol 225, 206–213.
24. Grunstein M (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349–352.
25. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E & Gong MC (2005). COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67, 723–735.
26. Gurbuz I, Ferralli J, Roloff T, Chiquet-Ehrismann R & Asparuhova MB (2014). SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients. Mol Cancer 13, 22.
27. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, Magnusson KE & Stralfors P (1999). Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13, 1961–1971.
28. Hayashi K, Watanabe B, Nakagawa Y, Minami S & Morita T (2014). RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling. PLoS One 9, e89016.
29. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H & Nishino I (2009). Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 119, 2623–2633.
30. Jin W, Goldfine AB, Boes T, Henry RR, Ciaraldi TP, Kim EY, Emecan M, Fitzpatrick C, Sen A, Shah A, Mun E, Vokes V, Schroeder J, Tatro E, Jimenez-Chillaron J & Patti ME (2011). Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest 121, 918–929.
31. Kawamura H, Yokote K, Asaumi S, Kobayashi K, Fujimoto M, Maezawa Y, Saito Y & Mori S (2004). High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 24, 276–281.
32. Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, Meier M, Nemani M, Bridel E, Leite CC, Bertola DR, Semple RK, O'Rahilly S, Dugail I, Capeau J, Lathrop M & Magre J (2008). Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93, 1129–1134.
33. Kovtun O, Tillu VA, Ariotti N, Parton RG & Collins BM (2015). Cavin family proteins and the assembly of caveolae. J Cell Sci 128, 1269–1278.
34. Krawczyk KK, Yao Mattisson I, Ekman M, Oskolkov N, Grantinge R, Kotowska D, Olde B, Hansson O, Albinsson S, Miano JM, Rippe C & Sward K (2015). Myocardin family members drive formation of caveolae. PLoS One 10, e0133931.
35. Li L, Liu Z, Mercer B, Overbeek P & Olson EN (1997). Evidence for serum response factor-mediated regulatory networks governing SM22α transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol 187, 311–321.
36. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH & Owens GK (2005). Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280, 9719–9727.
37. Lo HP, Nixon SJ, Hall TE, Cowling BS, Ferguson C, Morgan GP, Schieber NL, Fernandez-Rojo MA, Bastiani M, Floetenmeyer M, Martel N, Laporte J, Pilch PF & Parton RG (2015). The caveolin-cavin system plays a conserved and critical role in mechanoprotection of skeletal muscle. J Cell Biol 210, 833–849.
38. Masson O, Chavey C, Dray C, Meulle A, Daviaud D, Quilliot D, Muller C, Valet P & Liaudet-Coopman E (2009). LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue. PLoS One 4, e7422.
39. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B Jr, Reitman ML & Gonzalez FJ (2003). Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111, 737–747.
40. McDonald ME, Li C, Bian H, Smith BD, Layne MD & Farmer SR (2015). Myocardin-related transcription factor A regulates conversion of progenitors to beige adipocytes. Cell 160, 105–118.
41. Mendez MG & Janmey PA (2012). Transcription factor regulation by mechanical stress. Int J Biochem Cell Biol 44, 728–732.
42. Miano JM (2003). Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35, 577–593.
43. Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES & Rosen ED (2010). Comparative epigenomic analysis of murine and human adipogenesis. Cell 143, 156–169.
44. Miralles F, Posern G, Zaromytidou AI & Treisman R (2003). Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329–342.
45. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh EL & Silver DL (2014). Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509, 503–506.
46. Nilsson-Berglund LM, Zetterqvist AV, Nilsson-Ohman J, Sigvardsson M, Gonzalez Bosc LV, Smith ML, Salehi A, Agardh E, Fredrikson GN, Agardh CD, Nilsson J, Wamhoff BR, Hultgardh-Nilsson A & Gomez MF (2010). Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol 30, 218–224.
47. Nobusue H, Onishi N, Shimizu T, Sugihara E, Oki Y, Sumikawa Y, Chiyoda T, Akashi K, Saya H & Kano K (2014). Regulation of MKL1 via actin cytoskeleton dynamics drives adipocyte differentiation. Nat Commun 5, 3368.
48. Olson EN & Nordheim A (2010). Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 11, 353–365.
49. Oshikawa J, Otsu K, Toya Y, Tsunematsu T, Hankins R, Kawabe J, Minamisawa S, Umemura S, Hagiwara Y & Ishikawa Y (2004). Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci USA 101, 12670–12675.
50. Posern G & Treisman R (2006). Actin’ together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 16, 588–596.
51. 1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22α transcription in vivo. Circ Res 97, 983–991.
52. Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, Schulze A, Lucke B, Lutzkendorf S, Karbasiyan M, Bachmann S, Spuler S & Schuelke M (2010). Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet 6, e1000874.
53. Riches K, Alshanwani AR, Warburton P, O'Regan DJ, Ball SG, Wood IC, Turner NA & Porter KE (2014). Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. J Mol Cell Cardiol 74, 240–250.
54. Rikitake Y & Liao JK (2005). Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 111, 3261–3268.
55. Rosen ED, Walkey CJ, Puigserver P & Spiegelman BM (2000). Transcriptional regulation of adipogenesis. Genes Dev 14, 1293–1307.
56. Sawant A, Chanda D, Isayeva T, Tsuladze G, Garvey WT & Ponnazhagan S (2012). Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity. J Biol Chem 287, 12241–12249.
57. Schleicher ED & Weigert C (2000). Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int Suppl 77, S13–18.
58. Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, Morrisey EE, Ip HS & Parmacek MS (1995). Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem 270, 13460–13469.
59. Somogyi K & Rorth P (2004). Cortactin modulates cell migration and ring canal morphogenesis during Drosophila oogenesis. Mech Dev 121, 57–64.
60. Sotiropoulos A, Gineitis D, Copeland J & Treisman R (1999). Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159–169.
61. Spiegelman BM & Heinrich R (2004). Biological control through regulated transcriptional coactivators. Cell 119, 157–167.
62. Stone SJ, Myers HM, Watkins SM, Brown BE, Feingold KR, Elias PM & Farese RV Jr (2004). Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 279, 11767–11776.
63. Stralfors P (2012). Caveolins and caveolae, roles in insulin signalling and diabetes. Adv Exp Med Biol 729, 111–126.
64. Sun Q, Chen G, Streb JW, Long X, Yang Y, Stoeckert CJ Jr & Miano JM (2006). Defining the mammalian CArGome. Genome Res 16, 197–207.
65. Thi Hien T, Turczynska KM, Dahan D, Ekman M, Grossi M, Sjogren J, Nilsson J, Braun T, Boettger T, Garcia Vaz E, Stenkula K, Sward K, Gomez MF & Albinsson S (2016). Elevated glucose levels promote contractile and cytoskeletal gene expression in vascular smooth muscle via Rho/protein kinase C and actin polymerization. J Biol Chem 291, 3552–3568.
66. Towler DA, Bidder M, Latifi T, Coleman T & Semenkovich CF (1998). Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273, 30427–30434.
67. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH & Stoffel M (2011). MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649–653.
68. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M & Narumiya S (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990–994.
69. 2+ channels and protein kinase C. Cardiovasc Res 43, 1018–1028.
70. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA & Olson EN (2001). Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851–862.
71. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, Richardson JA, Nordheim A & Olson EN (2002). Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci USA 99, 14855–14860.
72. Vartiainen MK, Guettler S, Larijani B & Treisman R (2007). Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316, 1749–1752.
73. Weinl C, Castaneda Vega S, Riehle H, Stritt C, Calaminus C, Wolburg H, Mauel S, Breithaupt A, Gruber AD, Wasylyk B, Olson EN, Adams RH, Pichler BJ & Nordheim A (2015). Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke. Proc Natl Acad Sci USA 112, 9914–9919.
74. White RE & Carrier GO (1988). Enhanced vascular alpha-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol Heart Circ Physiol 255, H1036–H1042.
75. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L & Natarajan R (2010). Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 59, 2904–2915.
76. Villeneuve LM & Natarajan R (2010). The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 299, F14–F25.
77. Xie Z, Gong MC, Su W, Xie D, Turk J & Guo Z (2010). Role of calcium-independent phospholipase A2β in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals. J Biol Chem 285, 8628–8638.
78. Xie Z, Su W, Guo Z, Pang H, Post SR & Gong MC (2006). Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res 69, 491–501.
79. Xu H, Wu X, Qin H, Tian W, Chen J, Sun L, Fang M & Xu Y (2015). Myocardin-related transcription factor A epigenetically regulates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 26, 1648–1660.
80. Yin JW, Liang Y, Park JY, Chen D, Yao X, Xiao Q, Liu Z, Jiang B, Fu Y, Bao M, Huang Y, Liu Y, Yan J, Zhu MS, Yang Z, Gao P, Tian B, Li D & Wang G (2012). Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation. Genes Dev 26, 2192–2205.
81. Yin Y, Yuan H, Wang C, Pattabiraman N, Rao M, Pestell RG & Glazer RI (2006). 3-Phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Mol Endocrinol 20, 268–278.
82. Zeidan A, Nordstrom I, Albinsson S, Malmqvist U, Sward K & Hellstrand P (2003). Stretch-induced contractile differentiation of vascular smooth muscle: sensitivity to actin polymerization inhibitors. Am J Physiol Cell Physiol 284, C1387–C1396.
83. Zeidan A, Sward K, Nordstrom I, Ekblad E, Zhang JC, Parmacek MS & Hellstrand P (2004). Ablation of SM22α decreases contractility and actin contents of mouse vascular smooth muscle. FEBS Lett 562, 141–146.
84. Zeisberg M & Neilson EG (2010). Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21, 1819–1834.
85. Zhong Q & Kowluru RA (2013). Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 62, 2559–2568.